| Primary |
| Drug Use For Unknown Indication |
100.0% |
|
| Platelet Count Decreased |
50.0% |
| Thrombocytopenia |
50.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.3% |
| Ill-defined Disorder |
9.2% |
| Product Used For Unknown Indication |
6.5% |
| Acute Coronary Syndrome |
5.2% |
| Acute Promyelocytic Leukaemia |
5.2% |
| Pain |
4.6% |
| Gastritis Prophylaxis |
3.3% |
| Antiemetic Supportive Care |
2.6% |
| Atrial Fibrillation |
2.6% |
| Back Pain |
2.6% |
| Coronary Arterial Stent Insertion |
2.6% |
| Pharyngitis |
2.6% |
| Prophylaxis |
2.6% |
| Psoriasis |
2.6% |
| Psoriatic Arthropathy |
2.6% |
| Extrapyramidal Disorder |
2.0% |
| Hypothyroidism |
2.0% |
| Ligament Sprain |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Sciatica |
2.0% |
|
| Renal Failure Acute |
14.0% |
| Oesophageal Haemorrhage |
7.0% |
| Pruritus |
7.0% |
| Rash Pustular |
7.0% |
| Thrombocytopenia |
7.0% |
| Acute Generalised Exanthematous Pustulosis |
4.7% |
| Drug Effect Prolonged |
4.7% |
| Hyponatraemia |
4.7% |
| Leukopenia |
4.7% |
| Psoriasis |
4.7% |
| Renal Failure |
4.7% |
| Sudden Death |
4.7% |
| Urticaria |
4.7% |
| Vomiting |
4.7% |
| Weight Decreased |
4.7% |
| Anaemia Haemolytic Autoimmune |
2.3% |
| Hallucination, Visual |
2.3% |
| Histiocytosis Haematophagic |
2.3% |
| Liver Injury |
2.3% |
| Microalbuminuria |
2.3% |
|
| Concomitant |
| Hypertension |
16.8% |
| Drug Use For Unknown Indication |
15.0% |
| Product Used For Unknown Indication |
12.6% |
| Prophylaxis |
7.6% |
| Rheumatoid Arthritis |
6.2% |
| Pain |
5.2% |
| Osteoporosis |
4.2% |
| Herpes Zoster |
3.4% |
| Dyslipidaemia |
3.0% |
| Hiatus Hernia |
2.8% |
| Hypothyroidism |
2.8% |
| Anxiety |
2.6% |
| Facial Neuralgia |
2.6% |
| Menopause |
2.4% |
| Spondylitis |
2.4% |
| Arrhythmia |
2.2% |
| Hepatitis C |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Depression |
2.0% |
| Myocardial Ischaemia |
2.0% |
|
| Vomiting |
12.9% |
| Renal Failure Acute |
8.2% |
| Visual Field Defect |
8.2% |
| Muscle Contractions Involuntary |
7.1% |
| Tendonitis |
5.9% |
| Macular Degeneration |
4.7% |
| Syncope |
4.7% |
| Systemic Inflammatory Response Syndrome |
4.7% |
| Thrombocythaemia |
4.7% |
| Weight Decreased |
4.7% |
| Colitis Ulcerative |
3.5% |
| Epistaxis |
3.5% |
| Melaena |
3.5% |
| Memory Impairment |
3.5% |
| Pyrexia |
3.5% |
| Thrombocytopenia |
3.5% |
| Urinary Tract Infection |
3.5% |
| Vertigo |
3.5% |
| Vitamin D Deficiency |
3.5% |
| Anaphylactic Shock |
2.4% |
|
